Dasatinib therapy may therefore create an immunosuppressive environment that favors the expansion of pre-existing memory CD8+ T-cells, potentially mimicking the conditions encountered after allogeneic stem cell transplantation7 or during primary infection with certain persistent viruses44,45. Here, CD8A is linked to infection.